‘Transformative’ cancer treatment: FDA approves gene therapy that functions as a ‘living drug’ – Los Angeles Times
Los Angeles Times |
'Transformative' cancer treatment: FDA approves gene therapy that functions as a 'living drug'
Los Angeles Times In a step that heralds a new era in cancer treatment, the U.S. Food and Drug Administration said Wednesday it has approved a form of gene therapy that is highly effective at fighting an aggressive form of leukemia in young patients with no other options. FDA Approves First Gene Therapy For Leukemia Revolutionary gene therapy approved for leukemia — at $475000 price tag FDA approval brings first gene therapy to the United States |
